After a written consent was signed by the patient, an off-label intravitreal bevacizumab injection (1.25 mg) was given in the right eye. At 4 weeks, BCVA improved to 20/50 OD and FA showed staining of the neovascular membrane. The CMT on OCT decreased to 221 m OD with a reduction in lesion size (Figure 1 ). After 6 months, the vision was maintained at 20/50 OD with a scarred subfoveal membrane.
however, certain limitations like high expenses involved and post-treatment risk of vision loss are present.
In this case, bevacizumab not only hastened the regression of the neovascular membrane but also provided superior visual outcome. Intravitreal bevacizumab is also well tolerated and no adverse effects were observed. The results observed in this case are provocative and require further investigation. Sir, Retinal pigment epithelium tear after intravitreal bevacizumab injection for polypoidal choroidal vasculopathy A retinal pigment epithelium (RPE) tear is a well-recognized complication of pigment epithelial detachments (PEDs) in age-related macular degeneration (AMD), as well as in polypoidal choroidal vasculopathy (PCV). 1 Recently, several reports have recognized that an RPE tear can occur after anti-vascular endothelial growth factor (VEGF) therapy such as bevacizumab, ranibizumab, and pegaptanib for AMD. 2 In this report, we present a patient with PCV who developed an RPE tear after an intravitreal bevacizumab injection. On the basis of serial findings of optical coherence tomography, a possible mechanism was suggested as being responsible for the formation of RPE tears. (Figure 1c) . The upper part seemed wavy and contracted, and the lower part seemed smooth and distended. There was an obvious dimple (arrow) between these two features of PED. Another bevacizumab injection was given in the right eye. The patient noted worsening of metamorphopsia 1 week after the injection. Reevaluation 4 weeks after the injection revealed visual acuity of 20/70 in the right eye and an RPE tear was noted (Figure 2e ). Fluorescein angiography proved the presence of an RPE tear with macula involvement (Figure 2f ). Indocyanine green angiography revealed that the earlier polypoidal lesion and the branching choroidal vessels became less apparent at early phase (Figure 2g ) and late phase (Figure 2h ). Using optical coherence tomography, an RPE tear was disclosed at the edge of an earlier smooth feature of PED. The RPE band showed a wavy and retracted configuration, as well as a thickened appearance with adjacent RPE loss (Figure 2d ).
Case report

Comment
RPE tears are reported in 0.8-2.2% of patients with AMD after intravitreal injection of bevacizumab. 3, 4 They usually occur in large irregular PEDs associated with choroidal neovascularization. and may have potential risks similar to AMD with large PEDs after anti-VEGF therapy. However, we are unaware of any earlier reports of an RPE tear occurring after intravitreal bevacizumab injections for PCV.
Several mechanisms for the generation of RPE tears had been proposed. Chuang and Bird 6 found that the Bruch's membrane and hydrophobic deposits like drusen might act as a barrier to fluid flow. Gass 7 suggested that the tangential force exerted by the fibrovascular contraction of choroidal neovascular membrane might be responsible for RPE tears. Moreover, VEGF played a role in RPE barrier dysfunction. 8 The maintenance of the tight junction could be disrupted by VEGF. In the development of PED in exudative AMD, the distending force caused by rapid fluid accumulation intervenes with the contractile force of fibrovascular membrane. Treatments such as photodynamic therapy, laser photocoagulation, and anti-VEGF treatment may also induce an acute contraction of the fibrovascular membrane and increase the contractile force. [1] [2] [3] These two opposite forces may lead to the separation of RPE from Bruch's membrane and eventually cause the already weakened RPE to tear. As a larger and higher PED seemed to be more disposed to RPE tear, 3, 9 and the PEDs of PCV were found to be generally larger than the PEDs of the other aetiology, 1, 4 it is possible that PCV may be more prone to RPE tear. In our case, optical coherence tomography findings disclosed a highly irregular large PED with an obvious dimple, which might represent a boundary between the distended and the contracted parts of the PED. These two features within one PED showed an imbalance between hydrostatic and tangential forces. This may be an important indicator of the formation of RPE tears.
In summary, in this report, we showed that an RPE tear occurred after intravitreal bevacizumab injections for PCV with large irregular PED. Further studies are needed to evaluate the incidence and the amount of risk to eyes of developing RPE tears in polypoidal lesions with anti-VEGF therapy.
